Catalyst Wire Dossier Catalyst Wire Dossier

LV

leucovorin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LV, covering 2022-08-24 to 2022-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer [Phase 2]

See pricing